Medicare Advantage Spending Flagged as Hospital Fund Depletion Moves Up: 4 Notes

Medicare Advantage Spending Flagged as Hospital Fund Depletion Moves Up: 4 Notes

Becker’s Hospital Review
Becker’s Hospital ReviewJun 11, 2026

Why It Matters

An earlier depletion threatens hospital cash flow and could force beneficiaries to face higher out‑of‑pocket costs, prompting policymakers to consider financing reforms.

Key Takeaways

  • Hospital Insurance Trust Fund runs out by Q2 2033.
  • Coverage drops to 89% at depletion, 85% by 2050.
  • Medicare Advantage spending rise drives faster fund depletion.
  • Actuarial deficit widens to 0.56% of taxable payroll.
  • Part D drug costs surge, but Parts B/D fund stays solvent.

Pulse Analysis

The latest trustees’ projection that the Hospital Insurance Trust Fund will run out of cash by the second quarter of 2033 marks a pivotal shift in Medicare’s fiscal landscape. Part A, which funds inpatient hospital stays, skilled‑nursing facilities, home health and hospice care, has traditionally been a reliable safety net for both providers and patients. The new timeline shortens the previously expected 2036 cliff, signaling that the fund’s $255.7 billion reserve will be exhausted sooner than anticipated, and that benefit coverage could fall below full reimbursement within the next decade.

Two forces are driving the accelerated shortfall. First, Medicare Advantage enrollment continues to rise, and per‑capita spending in these private‑managed plans has been revised upward, eroding the traditional Part A base. Second, the enactment of H.R. 1, which reduces payroll tax growth, lowers the projected revenue stream that underwrites the trust fund. Together they expanded the 75‑year actuarial deficit to 0.56% of taxable payroll, up from 0.42% a year earlier, and pushed annual deficits back to 2027.

The ripple effects extend beyond the trust fund itself. Hospitals may confront tighter reimbursement rates, prompting cost‑containment measures or shifts toward outpatient care. Meanwhile, the trustees flagged a surge in specialty drug utilization for Part D, inflating prescription costs even as the Part B/D fund remains financially stable thanks to annual premium adjustments. Policymakers will need to balance reforms—such as premium hikes, benefit redesign, or additional federal contributions—to preserve the integrity of Medicare’s core hospital benefit while containing long‑term spending growth.

Medicare Advantage spending flagged as hospital fund depletion moves up: 4 notes

Comments

Want to join the conversation?

Loading comments...